Background {#Sec1}
==========

Clubfoot, or congenital talipes equinovarus (CTEV), is one of the most common congenital musculoskeletal deformities. Within the Africa region, clubfoot birth prevalence is estimated as 1.11 (95%CI 0.96--1.26) per 1000 live births \[[@CR1]\]. Untreated clubfoot results in pain, physical impairment and can ultimately cause disability \[[@CR2]\]. The Ponseti method is widely used for the management of clubfoot \[[@CR3]\]. It consists of two distinct phases, the correction phase and the maintenance phase \[[@CR4]\]. The correction phase involves precise manipulation of the foot around the talus to correct the cavus, adductus and varus of the deformity. The manipulation position is held in a long leg plaster of paris cast and the cast is typically changed weekly. A percutaneous tenotomy of the Achilles tendon is usually performed to correct the residual equinus. The maintenance phase involves the use of a foot abduction brace (FAB) for 23 h a day for three months, followed by nightly use until four to five years of age \[[@CR5]\].

Many classification systems have been proposed to assess the severity of the clubfoot deformity and to measure the impact of treatment \[[@CR6]\]. Ponseti and Smoley \[[@CR4]\] based their classification on clinical assessment of ankle dorsiflexion, heel varus, forefoot supination and tibial torsion after treatment. Feet were classified as good, acceptable or poor. Harrold and Walker \[[@CR7]\] considered the extent of deformity correction. The Pirani score \[[@CR8]\] and the Dimeglio score \[[@CR9]\] are two of the most widely used classification systems for clubfoot deformity \[[@CR10]\]. The Pirani score is from 0 to 6 where zero is a normal foot and six is the most severe deformity. It is reliable when used by non-specialist health workers \[[@CR11]\]. The Dimeglio score has a maximum of 20 points and the deformity is graded as benign, moderate, severe or very severe.

Tools that have been developed to assess function include: assessment of patient satisfaction and pain, gait, heel position and range of motion \[[@CR12], [@CR13]\]; a questionnaire designed to measure overall satisfaction, foot appearance, pain and physical limitations \[[@CR14]\]; and a detailed assessment of movement quality that requires mobility testing with a goniometer and muscle testing \[[@CR15]\], but does not include parent reported outcomes.

There is a need for a standardised approach to report clubfoot treatment outcomes \[[@CR16]--[@CR18]\]. To address this gap, this review aims to investigate the literature and to determine and evaluate how success with the Ponseti method is reported in sub-Saharan Africa.

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

A systematic literature search was conducted in August 2017 for peer-reviewed articles presenting original research findings on the effect of treatment of clubfoot in children in sub-Saharan Africa. Studies were limited to outcomes of the Ponseti method as this technique is widely accepted as best practice \[[@CR18]\]. There was no language restriction. Results are presented according to the PRISMA guidelines \[[@CR19]\].

Excerpta Medica Database (EMBASE), Global Health, Medline, Africa Wide Information and African Journals Online were examined for studies meeting the following inclusion criteria: \[[@CR1]\] evaluation of the effect of clubfoot management, \[[@CR2]\] use of the Ponseti method, \[[@CR3]\] original study undertaken in sub-Saharan Africa, and \[[@CR4]\] published between 1st January 2000 and 1st August 2017. Concepts were expanded to include related terms and synonyms. A study was excluded if there was no evaluation of treatment, however there was no restriction on type of study to allow a quality assessment review. There was no limitation on age of children and the search was restricted by date (2000--2017) to capture current best practice. Full search terms are presented in Table [1](#Tab1){ref-type="table"} and the search terms for the country names are outlined in detail in Additional file [1](#MOESM1){ref-type="media"}.Table 1Search terms for treatment of clubfoot with the Ponseti method in sub-Saharan Africa1clubf??t or club-f??t or (club ADJ1 foot) or (talipes ADJ1 equinovarus) or (talipes ADJ1 equino-varus) or (congenital ADJ1 talipes ADJ1 equinovarus) or (congenital ADJ1 talipes ADJ1 equino-varus) or CTEV2Ponseti3Country name in sub-Saharan Africa^a^41 AND 2 AND 3^a^Outlined in detail in Additional file [1](#MOESM1){ref-type="media"}

All titles and abstracts were screened independently by two authors (TS and DM). The full paper was reviewed if selected by either author or if the abstract was absent. In addition, the reference lists of the included articles were screened. Consensus was reached through discussion where there was disagreement on eligibility.

Data extraction {#Sec4}
---------------

A pilot-tested spread-sheet was used for data extraction from articles that met the inclusion criteria. All characteristics recorded by one author (TS) were reviewed for accuracy by another author (DM). Data extracted included authors, year of publication, type of study, sample size, age of participants, duration of follow up and reported measurement of treatment outcome. Two authors \[[@CR20], [@CR21]\] were contacted to provide missing information. Where other forms of treatment were detailed or where a paper included a country outside of sub-Saharan Africa, only data regarding the Ponseti method and from the sub-Saharan African country were extracted.

Assessment of study quality {#Sec5}
---------------------------

Full articles that met the eligibility criteria were categorised according to a hierarchy of study methodologies \[[@CR22]\] developed to assess intervention strategies used with children with developmental disabilities. Quality of evidence was ranked as:I.Systematic review of randomised controlled trials (RCTs); RCT with *N* \> 100II.RCT with *N* \< 100; Systematic review of cohort studiesIII.Cohort studies with concurrent control group; Systematic reviews of case control studiesIV.Case series; Cohort study without concurrent control group; Case-control studyV.Expert opinion; Case study or report; Anecdotal Evidence.

In addition to the levels of evidence, we used a quality measure proposed by Downs and Black \[[@CR23]\] to identify methodological strengths and weaknesses of the included studies as there was no limitation on type of study. The quality index is a 27-item checklist designed for use with both observational studies and randomised controlled trials. The index is comprised of five subscales: reporting (ten questions), external validity (three questions), internal validity (bias and confounding) (13 questions), and power (one question). Items are checked as 'yes', 'partially', 'no' or 'unable to determine' depending on the subscale and higher scores indicating higher quality. The maximum score is 32.

Data analysis {#Sec6}
-------------

The definition of success was determined by the primary outcome reported in the studies or if explicitly stated. There were no studies that were sufficiently homogenous in terms of participants and outcomes to include in a meta-analysis and data were not combined due to methodological and clinical heterogeneity. An integrative review method \[[@CR15]\] that included problem identification, data presentation and analysis was used to incorporate results. Summary statistics for the quality measure were calculated and include the mean and range (minimum and maximum).

Results {#Sec7}
=======

Search results {#Sec8}
--------------

A total of seventy-seven articles were identified. Twenty-two studies met the inclusion criteria. The search strategy and reasons for excluding articles are presented in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Search Strategy with PRISMA flow diagram

Study characteristics {#Sec9}
---------------------

Characteristics of the eligible studies are presented in Table [2](#Tab2){ref-type="table"} and include children from one day old \[[@CR21]\] to 10 years \[[@CR24]\].Table 2Characteristics of studies that report outcomes of the Ponseti method in sub-Saharan Africa^a^Primary Author Year CountryNumber of children and (feet) treatedAge RangeType of study (Level of Evidence)Comparator GroupDuration of Follow upIbraheem 2017 \[[@CR21]\], Nigeria23 (14)\<3 monthsRandomised controlled trial (II)Children managed by accelerated Ponseti treatment32--77 days.Malagelada 2016 \[[@CR32]\], South Africa65 (91)4--63 monthsCross sectional survey (IV)Cases in a UK urban clinicNot applicableSmythe 2016 \[[@CR35]\], Zimbabwe173 (268)17 days -- 5 years 7 monthsCase series, retrospective (IV)Pre-treatment status of cases10.2 weeks (9.5--10.9)Boakye 2016 \[[@CR38]\], Ghana271 (430)\<6 monthsCase series, Retrospective (IV)Pre-treatment status of casesNot reportedAdegbehingbe 2015 \[[@CR39]\], Nigeria4931 (7745)Not reportedCase series (IV)Pre-treatment status of casesNot reportedAdewole 2014 \[[@CR33]\], Nigeria106 (158)7 days -- 4 yearsCase series, prospective (IV)Pre-treatment status of casesMean: 3 years (range 2--4)Ayana 2014 \[[@CR24]\], Ethiopia22 (32)2--10 yearsCase series, prospective (IV)Pre-treatment status of casesNot reportedKouamo 2014 \[[@CR40]\], Togo24 (41)17 days - 7 yearsCase series, prospective (IV)Pre-treatment status of casesNot applicableMang'oli 2014, Kenya223 (361)Mean 23 monthsCross sectional survey (IV)Status of cases at previous appointmentOne yearKaseke 2013 \[[@CR41]\], Zimbabwe14 (20)Mean 7.43 weeksNon randomised, prospective (III)Children managed with Kite technique6 weeksAdegbehingbe 2012 \[[@CR42]\], Nigeria493 (749)Not reportedCase series, prospective (V)Pre-treatment status of casesNot reportedCashman 2012 \[[@CR20]\], Malawi\>2000Not reportedCase series (IV)No comparatorNot reportedPirani 2012 \[[@CR43]\], Uganda370Majority under 14 weeksCase series, prospective (IV)Pre-treatment status of casesNot reportedHarnett 2011 \[[@CR44]\], Malawi21 (32)\<2 monthsRandomised controlled trial (II)Children managed by accelerated Ponseti treatmentMean 258 days (70 to 348)Adegbehingbe 2010 \[[@CR25]\], Nigeria55 (80)\<18 yearsRandomised controlled trial (II)Children treated by surgery3--36 months post last castRadler 2010 \[[@CR45]\], Mali52\< 1 yearCase series (IV)Pre-treatment status of casesNot reportedFirth 2009 \[[@CR30]\], South Africa70 (106)1 day -- 40 monthsCase series, retrospective (IV)Pre-treatment status of casesMean: 2 years 5 monthsBiruk 2007 \[[@CR26]\], Ethiopia55 (82)\< 6 monthsCase series, prospective (IV)Children in different age categoryNot reportedLavy 2007 \[[@CR28]\], Malawi307 (482)\<12 monthsCase series, retrospective (IV)Pre-treatment status of casesNot reportedKhan 2005 \[[@CR27]\], South Africa(61)Not reportedCase series (IV)Pre-treatment status of casesNot reportedTindall 2005 \[[@CR29]\], Malawi75 (100)Under 4 yearsCase series, prospective (IV)Pre-treatment status of cases5 ft followed for 12-18 monthsMkandawire 2003 \[[@CR36]\], Malawi54Under 2 yearsCase series, Prospective (IV)Pre-treatment status of cases12 months^a^Ordered by year of publication

The quality of evidence that reported outcomes of the Ponseti method in sub-Saharan Africa was low. Studies were included from ten countries in sub-Saharan Africa; studies undertaken in Nigeria and Malawi contributed five papers each. There were three RCTs, all with small sample sizes of less than 100 children. The majority of studies were classed as level IV \[[@CR22]\] due to their observational nature.

Definition of success -- Primary outcome {#Sec10}
----------------------------------------

All authors described a form of clinical assessment to assess outcome of treatment. Only 14 studies (64%) gave a clear definition of success. The Pirani score was defined as the primary outcome measure to assess the deformity correction in 14 studies. Change in the mean Dimeglio score was evaluated in one study \[[@CR25]\] and frequency of initial severity was reported with the Harrold-Walker classification in two studies \[[@CR26], [@CR27]\]. Other definitions of primary outcome included: the number of days in casts \[[@CR21]\], number of patients treated without extensive surgery \[[@CR25]\], a plantigrade foot \[[@CR24], [@CR28], [@CR29]\], no residual deformity \[[@CR30]\], deformity status compared to previous visits \[[@CR31]\] and parent reported outcomes on impact of treatment \[[@CR32]\]. Limited definition terms included "complete correction" \[[@CR26]\] and "satisfactory outcome" \[[@CR25]\]. The approach to reporting severity scores varied (Table [3](#Tab3){ref-type="table"}).Table 3Reported Primary Outcome using the Ponseti method in sub-Saharan AfricaPrimary Author Year Country\*Clubfoot severity assessmentReported Success MeasureRecurrence / relapseAdditional surgical interventionIbraheem 2017 \[[@CR21]\], NigeriaPirani scoreNumber of days in casts, number of casts appliedNot reportedNot reportedMalagelada 2016 \[[@CR32]\], South AfricaPirani scoreParent reported outcomes12% (8 children)Not reportedSmythe 2016 \[[@CR35]\], ZimbabwePirani Score85% feet; Pirani score \< 1Not reportedNot reportedBoakye 2016 \[[@CR38]\], GhanaPirani ScoreNumber of casts to correction. Correction not defined.Not reportedNot reportedAdegbehingbe 2015 \[[@CR39]\], NigeriaNot reported89.7% (4426 patients) satisfactory outcome. Criteria for satisfactory outcome not defined.4% (253 feet, 194 patients)3%Adewole 2014 \[[@CR33]\], NigeriaPirani score and photograph100%; based on clinical judgement, Plantigrade functional foot5.16% (8 feet)6 feetAyana 2014 \[[@CR24]\], EthiopiaPirani score28/41 good results Good = correction of all deformities. 97.8% achieved score of \<32 patients, 4 feet8 children/ (11 feet)Kouamo 2014 \[[@CR40]\], TogoNot reported94% (179/190) compliant with brace wear 93.5% no visible discomfort12.2% (5 cases)Not reportedMang'oli 2014 , KenyaPirani scoreInitial correction: 96.2% (152 feet) Initial correction not defined.Not reportedNot reportedKaseke 2013 \[[@CR41]\], ZimbabwePirani scoreRate of correction: Pirani score at 3 weeks and 6 weeksNot reportedNot reportedAdegbehingbe 2012 \[[@CR42]\], NigeriaPirani Score89.7% treated successfully. Criteria for success not defined.Not reported3.2% (16 patients)Cashman 2012 \[[@CR20]\], MalawiNot reported30 children failed treatment (required more extensive surgery)Not reported30 childrenPirani 2012 \[[@CR43]\], UgandaPirani ScoreMean score 5.4 falls to \<2 by cast 6. Primary outcome not defined.Not reportedNot reportedHarnett 2011 \[[@CR44]\], MalawiPirani ScorePirani score change. Median start Pirani: 5 (4 to 6). Median at tenotomy /end treatment: 0.5 (0.5 to 1) Median at 6 months: 0.5 (0 to 0.5)No episodes of recurrence after 6 months3 patients not corrected (7%) with Pirani \>1Adegbehingbe 2010 \[[@CR25]\], NigeriaDimeglio classification96.4% (53/55 children) = satisfactory (No recurrence) 3.6% (2/55) = fair (recurrence corrected with casts/FAB) Nil = poor (recurrence with repeat surgery)2 had recurrence between 4 and 6 monthsNoneRadler 2010 \[[@CR45]\], MaliNot reported77% (40 children): good or average. 23% (12 children): poor. Primary outcome not defined.Not reportedNot reportedFirth 2009 \[[@CR30]\], South AfricaPirani score61% fully corrected without residual deformity23% (re-plaster 24 feet) 39% (41 feet mild recurrence)7% (7 feet)Biruk 2007 \[[@CR26]\], EthiopiaHarrold-Walker classification76.8% (63 feet) No definition of complete correction.Not reportedNot reported for Ponseti cohortLavy 2007 \[[@CR28]\], MalawiPirani score68% (327/482) Plantigrade or betterNot reported12 children referred for surgeryKhan 2005 \[[@CR27]\], South AfricaHarrold-Walker classification6 failures from 61 feet. Criteria for success not defined.Not reportedNot reportedTindall 2005 \[[@CR29]\], MalawiPirani score98% plantigrade foot with Pirani scoreNot reported2%Mkandawire 2003 \[[@CR36]\], MalawiPirani scoreCorrection of deformity. Success of correction defined as fitting brace. Mean Pirani score decreased from 3.6--0.864 children with untreated clubfoot, 5 with complex and 7 with teratologicNot reported\*Ordered by year of publication

Process outcomes {#Sec11}
----------------

There was wide variation in the measurement of process outcomes. The point in treatment when the number of casts was calculated was either before or after the final post tenotomy cast and was inconsistently described. Studies either reported frequency of tenotomy per child or per foot. Definition of relapse or recurrence of deformity differed in the included studies and technical details were only described in five studies (23%).

Six studies report on brace use \[[@CR25], [@CR28], [@CR30]--[@CR33]\] with the focus on non-compliance. Non-compliance was not well defined in the studies and varied from 2% to 44%.

One study assessed parent reported outcomes. The study aimed to determine the impact of the casting and bracing phases of the Ponseti method on the family. Each caregiver completed three questionnaires \[[@CR32]\] in order to examine the level of impact that Ponseti treatment had on lives of caregivers and the coping strategies employed.

Reported process outcomes are presented in Table [4](#Tab4){ref-type="table"}.Table 4Outcomes of the Ponseti Method reported in sub-Saharan Africa^a^Primary Author (Year) CountryProcess OutcomesAverage number of castsDuration of castsPercutaneous Achilles TenotomyReceipt of bracesBrace complianceLoss to follow upComplicationsIbraheem (2017 Nigeria5.4352 days (35--77)1 child did not have tenotomy, not reported case or control100%Not reportedNilReported no complications with swellingMalagelada (2016) South Africa8.7 (range 1--24)Not reported89% (58 children)100% due to inclusion criteria2% (1 child) non-compliantNot applicableDefined as relapse and non-compliance: 9 childrenSmythe (2016) Zimbabwe7.27 (6.7--7.9)10.2 (9.5--10.9) weeks included tenotomy78.9% (127/161 children)Not reportedNot reported8.9% (17 children)Not reportedBoakye (2016) Ghana4.93Not reported77%Not reportedNot reportedExcluded from analysisNot reportedAdegbehingbe (2015) NigeriaNot reportedNot reported77% (5626 children)Not reportedNot reportedNot reportedNot reportedAdweole (2014) Nigeria4.6 (range 3--9)Weekly cast change, tenotomy 3 weeks26.6% (42 feet)56.8% (60 patients)No child with relapse wore bracesNot reported9 feet: cast complications, blisters, ulcers, skin rashAyana (2014) Ethiopia8 (range 6--10)Casts changed every 2 weeks63.6% (14 children, 21 feet)100%; \< 4 yrs. = FAB \>4 yrs. = ankle foot orthosisNot reported1 patientNo major complicationsKouamo (2014) TogoNot reportedNot reported82.9% (34/41 feet)Not reportedNot reportedNot reportedNot reportedMangoli (2014) KenyaNot reportedNot reportedNot reported100% of interviewed parents15% (33/223) non-compliant Mean use 18 months (6--23)Not applicable5% (11/223) skin lesionKaseke (2013) ZimbabweNot reportedNot reportedNot reportedNot reportedNot reported6 feet not reported at 6 weeksNot reportedAdegbehingbe (2012) NigeriaNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedCashman (2012) MalawiNot reportedNot reported\>80%Not reportedNot reported107 childrenNot reportedPirani (2012) UgandaNot reportedMajority corrected by 6th treatment'Not reportedNot reportedNot reported83% adherence rate to end of castingPlaster burns in 19/1000Harnett (2011) MalawiMedian 5 (4--7)42 days (35--84) in plaster prior to tenotomy.52% (11 children)Given FAB to wear until 3 years oldNot reported2 after plaster. 1 patient diedNot reportedAdegbehingbe (2010) Nigeria≤ 6 (76.4%; range 2--6) \>6 (23.6% range 7--10)2.3--13.7 +/−1.7 weeks5.5% (3 children)Not reportedNoted as 'generally good'None, not explicitly mentioned3.6% ugly scar, recurrence, blister, infectionRadler (2010) MaliNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedFirth (2009) South Africa6.5 (range 2--18)Not reported74% (78 feet)Received FABs, % unspecified16% (11 patients) non-compliantNot reported8% (9 feet) minor blistering from bracesBiruk (2007) EthiopiaMaximum cast 17 timesWeekly cast changeNot reported60%, average wait time 3-4 monthsNot reportedNot reportedNot reported for Ponseti cohortLavy (2007) MalawiNot reportedNot reported37% had tenotomy44% given FABs44% (145/327 feet)32% (155 feet)307 adequate recordsKhan (2005) South AfricaNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedNot reportedTindall (2005) Malawi5.3Mean treatment 9.1 weeks41%AllNot reportedNot reported2 minor complicationsMkandawire (2003) MalawiWeekly cast changeMean treatment: 7.4 weeks for idiopathic, 7.1 weeks for complexNot reportedNot reportedNot reported32 patients (35%)Not reported^a^Ordered by year of publication

According to the quality assessment (Additional file [2](#MOESM2){ref-type="media"} outlines the individual study results using the Downs and Black (1998) criteria), the mean quality score of the included studies was 14.8 (5--21).

Reporting {#Sec12}
---------

Reporting was the highest scoring category of the quality assessment. All studies included a clear study hypothesis and aim and the majority (17/22) clearly described the characteristics of the patients and the intervention. However, while some distributions of principle confounders were partially described, few studies accounted for confounding in the study design or analysis. Loss to follow up was only reported in half of the studies. Few studies demonstrated a comprehensive attempt to measure adverse effects.

External validity {#Sec13}
-----------------

Many children were recruited from University and tertiary hospitals or national centres and therefore external validity was limited as the interventions undertaken in a specialist centre are likely unrepresentative of the hospitals most of the source population would attend.

Internal validity -- Bias and confounding {#Sec14}
-----------------------------------------

Randomisation is not possible in cohort studies and in the studies where randomisation was used, it was not possible to determine if the intervention assignment was concealed from both parents and staff until recruitment was complete and irrevocable. Characteristics of losses of patient follow up were inconsistently taken into account and reported in seven (32%) studies. Statistical tests used to assess the main outcomes and why they were chosen were inconsistently described; for example, median, mean and maximum of the number of casts used to achieve correction are reported in different papers. Power calculations were only outlined in three studies.

Discussion {#Sec15}
==========

This literature review comprises results from case series, prospective trials and cross-sectional surveys in sub-Saharan Africa. There were few comparative studies concerning the Ponseti method in the region and there were no agreed protocols for reporting the results and outcome of treatment. Due to ethical considerations, most trials investigating treatment of clubfoot are not randomised controlled trials (RCTs) but comparisons of treatments or a review of cohort outcomes. Potential sources of bias in observational studies are well documented \[[@CR34]\] and whilst systematic reviews of health care interventions most often focus on RCTs, the inclusion of cohort studies in this review highlights the need for quality design and reporting of studies to increase the strength of evidence.

Principal findings and considerations {#Sec16}
-------------------------------------

A definition of a primary outcome (success) was described in 14 of the 22 studies. Successful outcome ranged from 68% to 98% of cases using different definitions in the 14 studies. There was no consensus on how to define a successful outcome of treatment. There was selective reporting of positive results with little detail given to treatment failure \[[@CR35]\]. A range of process measures was included in the studies. The mean number of casts required ranged from 4.6 to 8.7 and is likely affected by the point at which the last cast was measured (pre- or post-tenotomy) and the unlimited age range of the review criteria. The studies used different criteria for relapse recognition and management. Two studies reported patient attrition over 30% \[[@CR28], [@CR36]\] however the length of follow-up in the majority of studies was short and few data were available on characteristics of children lost to follow up.

Acknowledging the limitations of the available reported papers, this review suggests that the Ponseti method appears to give successful correction of clubfoot during the correction phase when measured by the Pirani score, Dimeglio classification or simple clinical assessment. However, the lack of a consistent measure of success and insufficient follow up of cases restricts the conclusions that can be made about what happens during the bracing phase, be it success, recurrence or loss to follow-up.

Main findings as related to other publications {#Sec17}
----------------------------------------------

The included studies report success in 68% to 98% of cases after the correction (casting) phase. In contrast, global success rates after the correction phase are cited as approximately 90% \[[@CR18], [@CR37]\]. Comprehensive tools to assess function (e.g. as described by Laaveg and Ponseti (12), the Roye tool \[[@CR14]\], the Bangla tool \[[@CR13]\] or the Clubfoot Assessment Protocol (CAP) \[[@CR15]\]) are not reported in the studies from sub-Saharan Africa.

Implications of findings {#Sec18}
------------------------

We found that the differences between study populations, methodology and the way that outcomes are described contribute to the variation in results reported for the Ponseti method in sub-Saharan Africa. Currently, different scores are used for the assessment of clubfoot severity. Standardisation is required to define successful outcome of clubfoot management so that risk factors for good and poor outcome can be determined and services can be monitored and evaluated.

The Pirani score was the most frequent clinical assessment used. It has been validated in younger children and demonstrates acceptable interrater reliability \[[@CR8]\]. A short assessment time is required and it is easy to use, however to ensure consistency more guidance would be helpful on how to measure the individual components, as similarly provided by the diagrams and video produced to aid assessment with the Dimeglio score. The Pirani scoring system is the only assessment that has evidence for use by paramedics, and is in our opinion the easiest severity measure to use in young children before walking age.

Methodologic issues {#Sec19}
-------------------

To our knowledge, this is the first systematic review of outcomes to measure success of the Ponseti method in sub-Saharan Africa. The observation of explicit methodology and lack of language restriction are strengths of this study. The literature available to assess success of clubfoot treatment is characterised by a lack of standardisation of outcomes. Studies routinely use the term "success rates" but do not define a successful outcome. Given that Ponseti management involves both correction and maintenance, the definition of success should always reflect both of these important endpoints and we encourage researchers to measure and report both. Bias in internal validity arose from studies where differences in follow up were regularly ignored, however compliance with the corrective phase of the intervention was generally reported as being good. Studies must include follow-up or acknowledge the limitations of selecting one part of the treatment process.

The potential for confounding in the reviewed studies to obscure true effects is significant as the majority are observational. Randomisation may be considered unethical in certain circumstances and well designed controlled trials may provide more opportunities to analyse different outcomes. Studies intended to address comparative effectiveness of management for clubfoot should use a careful control for covariates such as unilateral or bilateral clubfoot as disproportionate weighting is given to bilateral cases \[[@CR17]\].

Research gaps {#Sec20}
-------------

Although a number of studies are available on initial treatment (correction phase) outcomes, very few studies are available on long term outcomes and follow up in the bracing phase, which are essential for measuring success of the entire Ponseti method.

No study compared different scoring systems. A study comparing multiple assessments in the same patient before and after treatment would be of value in assessing the equivalence or superiority of measurement techniques.

Studies need to control for the side of clubfoot and previous treatment, account for loss to follow up and adjust for confounding in methods or analysis in order to avoid the shortfalls of the current observational literature.

Recommendations {#Sec21}
---------------

Consensus is needed to standardise the reporting of outcomes and how success after Ponseti management is defined. For sub-Saharan Africa the definition needs to be appropriate for use by trained therapists who are managing children with clubfoot. This systematic review contributes to the knowledge about the importance of providing evidence to improve clubfoot services.

Conclusions {#Sec22}
===========

The lack of good quality studies, variation in definition of success and limited follow-up of patients means the success rate of clubfoot treatment using the Ponseti method in sub-Saharan Africa is uncertain. There is need for an agreed definition of good outcome following both the correction and the bracing phase to monitor and evaluate service delivery and identify reasons for poor outcome. It is very important that children who complete the correction phase are followed through the bracing phase and results on success, recurrence and loss to follow up are reported. Studies are also required to document the correlation between clinical outcome, functional outcome and patient/family reported satisfaction.
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 {#Sec23}
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